{"id":3043,"date":"2020-01-22T07:04:53","date_gmt":"2020-01-22T07:04:53","guid":{"rendered":"https:\/\/www.chirita-law.com\/?p=3043"},"modified":"2025-12-29T09:47:36","modified_gmt":"2025-12-29T07:47:36","slug":"obligare-autoritati-asigurare-gratuita-tratament-medicamente-off-label","status":"publish","type":"post","link":"https:\/\/chirita-law.com\/en\/obligare-autoritati-asigurare-gratuita-tratament-medicamente-off-label\/","title":{"rendered":"Dreptul la via\u021b\u0103. Obligarea autorit\u0103\u021bilor de a asigura gratuit tratamentul cu medicamente off-label"},"content":{"rendered":"<p class=\"wp-block-paragraph\">La data de 21 ianuarie 2020, Curtea de Apel Cluj, Sec\u0163ia a III-a contencios administrativ \u015fi fiscal, a admis cererea de emitere a unei ordonan\u021be pre\u0219edin\u021biale, sens \u00een care a\u00a0obligat p\u00e2r\u00e2\u0163ii, f\u0103r\u0103 soma\u0163ie \u015fi f\u0103r\u0103 trecerea unui termen, la asigurarea c\u0103tre reclamant\u0103 a tratamentului de substitu\u0163ie cu alfa-1 antitripsin\u0103 &#8211; \u00eencadrat la medicamente off-label,  \u00een regim de compensare 100%, f\u0103r\u0103 contribu\u0163ie personal\u0103, p\u00e2n\u0103 la solu\u021bionarea pl\u00e2ngerilor prealabile de c\u0103tre p\u00e2r\u00e2\u021bi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reclamanta,\nU.S., sufer\u0103 de o afec\u0163iune extrem de rar\u0103, fiind diagnosticat\u0103 cu Paniculit\u0103 prin Deficit de Alfa-1\nAntitripsin\u0103. Aceast\u0103 boal\u0103 se manifest\u0103 prin inflama\u021bii ale \u0163esutului adipos subcutanat, precum \u0219i ulcera\u021bii acute la nivelul membrelor \u0219i \u00een zona maxilo-facial\u0103. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Toate aceste simptome\ns-au agravat de-a lungul timpului, sens \u00een care reclamanta a fost nevoit\u0103 s\u0103\nsufere p\u00e2n\u0103 \u00een prezent peste 150 de interven\u021bii chirurgicale. A\u0219adar,\na ajuns \u00een etapa \u00een care corpul s\u0103u nu mai suporta interven\u0163ii chirurgicale de\nrecontruc\u0163ie a zonelor afectate de ulcera\u0163ii cu grefe de piele, din cauza\nimposibilit\u0103\u0163ii prelev\u0103rii acestora din alte zone ale corpului.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen urma\ninvestiga\u021biilor medicale, s-a concluzionat c\u0103 unica salvare pentru doamna U.S.\nconst\u0103 \u00een tratamentul de substitu\u0163ie cu alfa-1 antitripsin\u0103,\ncare se poate realiza prin intermediul unui medicament neautorizat \u00een Rom\u00e2nia.\nLa nivel european, prospectul medicamentului vizeaz\u0103 forma comun\u0103 a afec\u0163iunii,\niar nu \u0219i cazul particular al reclamantei. Pe\ncale de consecin\u021b\u0103, acordarea medicamentului \u00een regim de\ncompensare 100% nu era posibil\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De\u0219i sesizate cu problemele reclamantei, organele statatului au\nr\u0103mas \u00een pasivitate, neefectu\u00e2nd niciun demers efectiv pentru a demara procedurile administrative viz\u00e2nd decontarea\nmedicamentelor <em>off-label<\/em>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De altfel, <a href=\"http:\/\/www.ms.ro\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ministerul S\u0103n\u0103t\u0103\u0163ii<\/a> a recunoscut \u00een repetate r\u00e2nduri necesitatea \u00eenfiin\u021b\u0103rii unei Comisii pentru aprobarea decont\u0103rii medicamentelor pentru indica\u0163iile terapeutice neincluse \u00een rezumatul caracteristicilor produsului, \u00eens\u0103 p\u00e2n\u0103 la momentul pronun\u021b\u0103rii prezentei solu\u021bii, aceast\u0103 comisie nu a fost \u00eenfiin\u021bat\u0103. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A\u0219adar, reclamanta s-a pl\u00e2ns de faptul c\u0103 omisiunea p\u00e2r\u00e2\u021bilor de a-i asigura medicamenta\u021bia necesar\u0103 pentru a r\u0103m\u00e2ne \u00een via\u021b\u0103 reprezint\u0103 o grav\u0103 \u00eenc\u0103lcare a <a href=\"http:\/\/www.cnas.ro\/casvl\/media\/pageFiles\/Conventia%20CEDO.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">art. 2 din Conven\u021bia European\u0103 a Drepturilor Omului<\/a>, cu at\u00e2t mai mult cu c\u00e2t refuzurile primite p\u00e2n\u0103 la acel moment au fost \u00eentemeiate exclusiv pe propria culp\u0103 a autorit\u0103\u021bilor competente: lipsa cadrului legislativ adecvat.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen acest sens, reclamanta a ar\u0103tat c\u0103, potrivit legii, lista\nmedicamentelor poate fi oric\u00e2nd modificat\u0103, iar nu doar\nla cererea de\u0163in\u0103torilor autoriza\u0163iilor de punere pe pia\u0163\u0103, ci chiar \u015fi din\nini\u0163iativa autorit\u0103\u0163ilor p\u00e2r\u00e2te, inclusiv \u00een sensul extinderii indica\u0163iilor\nterapeutice ale unui produs pentru care se acord\u0103 compensarea. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Astfel, \u00een temeiul obliga\u021biei pozitive a statului de a lua m\u0103surile necesare pentru ap\u0103rarea vie\u0163ii celor afla\u0163i sub jurisdic\u0163ia sa, cererea reclamanei a fost admis\u0103. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reclamanta a fost asistat\u0103 de o echip\u0103 format\u0103 din avocat Roxana Gafi\u0163a, <a href=\"https:\/\/chirita-law.com\/en\/team\/cosmina-seulean\/\" target=\"_blank\" rel=\"noreferrer noopener\">avocat Cosmina \u015eeulean<\/a>, <a href=\"https:\/\/chirita-law.com\/en\/team\/oana-lup\/\" target=\"_blank\" rel=\"noreferrer noopener\">avocat Oana Lup<\/a>, coordonat\u0103 de <a href=\"https:\/\/chirita-law.com\/en\/team\/raluca-colcieri\/\" target=\"_blank\" rel=\"noreferrer noopener\">avocat Raluca Colcieri<\/a> \u015fi <a href=\"https:\/\/chirita-law.com\/en\/team\/oana-chirita\/\" target=\"_blank\" rel=\"noreferrer noopener\">avocat Oana Chiri\u0163\u0103<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>La data de 21 ianuarie 2020, Curtea de Apel Cluj, Sec\u0163ia a III-a contencios administrativ \u015fi fiscal, a admis cererea de emitere a unei ordonan\u021be pre\u0219edin\u021biale, sens \u00een care a\u00a0obligat p\u00e2r\u00e2\u0163ii, f\u0103r\u0103 soma\u0163ie \u015fi f\u0103r\u0103 trecerea unui termen, la asigurarea c\u0103tre reclamant\u0103 a tratamentului de substitu\u0163ie cu alfa-1 antitripsin\u0103 &#8211; \u00eencadrat la medicamente off-label, \u00een [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4087,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[40],"tags":[130,131,132,133,134,135],"class_list":["post-3043","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-consultanta-juridica-generala","tag-dreptul-la-viata","tag-interventii-chirurgicale","tag-medicamente-off-label","tag-ministerul-sanatatii","tag-paniculita","tag-regim-de-compensare"],"acf":[],"_links":{"self":[{"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/posts\/3043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/comments?post=3043"}],"version-history":[{"count":0,"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/posts\/3043\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/media\/4087"}],"wp:attachment":[{"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/media?parent=3043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/categories?post=3043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chirita-law.com\/en\/wp-json\/wp\/v2\/tags?post=3043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}